Navigation Links
Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
Date:4/25/2012

BIRMINGHAM, Ala., April 25, 2012 /PRNewswire-USNewswire/ -- Southern Research today announced that it has signed an agreement with Apath, LLC  which will allow Southern Research to conduct laboratory testing, research, and/or screening of potential therapeutic agents for hepatitis C (HCV) on an exclusive, fee-for-service basis using Apath's HCV virus-based technology.

Apath—a privately held technology company focusing on HCV and other human viral pathogens—was founded by Charles M. Rice, Ph.D., Professor at The Rockefeller University and formerly of the Washington University School of Medicine.

"Preclinical screening using a virus-based system will advance potential treatments for the disease because new therapies for HCV will be screened against the actual virus rather than a subset of the replication machinery," said Andrew D. Penman, Ph.D. vice president of Drug Development at Southern Research. "We are very pleased to work with Dr. Rice, a world renowned HCV expert and offer this new service to our clients."

Most preclinical drug screening for new HCV therapies use cell lines that harbor replicons—intracellular sub-genomic, self-replicating RNA molecules that contain the nucleotide sequences required for RNA replication, transcription, and translation, but are not themselves infectious.

Using a virus-based system, researchers can now develop antiviral treatments targeting viral entry into the cell, all of the replication machinery of the replicon, as well as downstream events such as viral assembly and release from the cell. As such, the entire viral life cycle is available for drug discovery and development.

"Successful treatment for chronic hepatitis C, given HCV diversity and the spectrum of disease, is likely to require combination therapy and new drugs well beyond those already approved," said Dr. Rice.

"As part of our commitment to remaining the global leader in the sublicensing of HCV-related technologies, I am particularly pleased with the expansion of our contract services agreement with Southern Research Institute, and I am extremely encouraged by the potential of this business venture assisting our clients in the fight against hepatitis C," said Robert M. Roth, Apath vice president, Strategic Operations. 

Southern Research conducts both contract research and basic research for clients, providing preclinical drug discovery, development, and clinical trial support services in cancer, infectious diseases, and CNS/neurological disease to pharmaceutical and biotechnology companies. Scientists conduct translational science to invent small molecules and advance them from the design stage to the clinic. Services available include medicinal chemistry, molecular biology, biochemistry, high-throughput screening and a full set of in-house GLP development services including toxicology, ADME/PK, animal models, formulations, and bioanalytical services.

ABOUT SOUTHERN RESEARCH
Southern Research Institute is a not-for-profit 501(c)(3) scientific research organization founded in 1941 that conducts preclinical drug discovery and development, advanced engineering research in materials, systems development, and environment and energy research. More than 550 scientific and engineering team members support clients and partners in the pharmaceutical, biotechnology, defense, aerospace, environmental and energy industries. Southern Research is headquartered in Birmingham, Ala., with facilities in Wilsonville, Ala., Frederick, Md., and Durham, NC and offices in Huntsville, Ala., New Orleans, La., and Washington, DC. 

CONTACT: Rhonda Jung
205-337-9634
Jung@SouthernResearch.org


'/>"/>
SOURCE Southern Research Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunpeaks Ventures Inks Sponsorship and Marketing Agreement with Major Sports Team, Clotamin To Be Sold at Walgreens Locations Throughout Oregon and Southern Washington
2. The Lanier Law Firms Dana Taschner Recognized Among Southern Californias Top Lawyers
3. Wellington Hospital, New Zealand Becomes First in Southern Hemisphere to Offer Patients Fast and Precise TrueBeam Treatments
4. Medical Oncology Association of Southern California, Cardinal Health Specialty Solutions Collaborate With Payors to Improve Quality, Costs, Accessibility of Cancer Care
5. Southern Home Medical Achieves Strong Third Quarter Results
6. Cardium to Present at Southern California Investor Conference
7. Innovative Dialysis Systems, Inc., Announces Opening of Four New Dialysis Facilities in Southern California
8. Southern Research Names Mark Suto Vice President of Drug Discovery
9. HASCO Medical Inc. Names Mike Dumais the Vice President of Sales for Southern Medical and Mobility
10. A New Audio Interview With Jerry Overcash, Director for Southern Home Medical Equipment, Inc., is now at SmallCapVoice.com
11. Southern Home Medical Equipment Reports Significant Growth from Encore Franchisees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2019)... ... , ... MindShare Technology Founder and CEO Greg Povolny will offer his insights ... and Communities National Conference. The conference is at the Westin Indianapolis hotel in Indianapolis, ... , Povolny’s presentation will provide real world examples of how to apply complex ...
(Date:10/10/2019)... ... 2019 , ... Global Composer & Activist Nenad Bach Chairs ... Championships, October 11th – 13th,  , The debilitating effects of Parkinson’s disease left Nenad ... find a way to combat the disease. A friend invited him to play ...
(Date:10/10/2019)... ... , ... Smile Brands Inc. together with its affiliate A+ Dental Care announced ... new A+ location in Natomas. , A+ Dental Care (“A+”) is a rapidly growing ... general dentists and three specialists work together as a team to provide comprehensive, personalized ...
Breaking Medicine Technology:
(Date:10/15/2019)... RICHMOND, Calif. (PRWEB) , ... October 14, 2019 , ... ... Network West to ride atop the Donate Life Rose Parade® float in the ... impacted by organ and tissue donation across Northern California and Northern Nevada, the organization’s ...
(Date:10/15/2019)... (PRWEB) , ... October 15, 2019 , ... Genomenon® ... partnership with SOPHiA GENETICS that includes incorporating the Mastermind® Genomic Search ... puts the most up-to-date genomic research at the fingertips of clinical researchers performing genomic ...
(Date:10/11/2019)... (PRWEB) , ... October 11, 2019 , ... A Topping ... (STA) new headquarters facility by general contractors Adolfson & Peterson Construction. The event celebrated ... 2020 at 8190 Midtown Road in Dallas. The first of its kind in Texas, ...
(Date:10/10/2019)... (PRWEB) , ... October 10, 2019 , ... ... Nutrition) Annual Conference, Nutrition 21 was excited to hear the significant results of ... significant blood flow impact of Nitrosigine®. The clinical study poster entitled “The Acute ...
(Date:10/8/2019)... AVON, Conn. (PRWEB) , ... October 08, 2019 ... ... fertility centers, recently acquired a majority interest in Advanced Fertility Care (AFC), an ... entities are joining forces to expand the availability of RE services to expectant ...
Breaking Medicine News(10 mins):